Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Enhancing Veteran-Clinical Collaboration in VA PRRCs [NA]
A VA-sponsored initiative aims to enhance veteran-clinical collaboration within VA PRRCs; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder [Phase 3]
Phase 3 clinical trial evaluating KarXT for manic episodes in Bipolar I disorder is recruiting. The study is sponsored by Bristol-Myers Squi…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder [Phase 2]
This is a Phase 2 clinical trial evaluating adverse events and changes in disease activity of oral Icalcaprant in adults with bipolar I or I…
-
FDA approval · 2026-04-13FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's supplemental application for lurasidone hydrochloride, signifying an update to the product's …
-
FDA approval · 2026-04-13FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Lamotrigine from Alembic Pharmaceuticals Limited under ANDA 090607.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-04-13EMA Authorised: Aripiprazole Sandoz (aripiprazole) — Sandoz GmbH
The European Medicines Agency authorised Aripiprazole Sandoz (aripiprazole) by Sandoz GmbH for treating schizophrenia and bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms [NA]
A completed clinical trial evaluated a psychobehavioral intervention aimed at regularizing daily rhythms to reduce suicide risk in adolescen…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder [Phase 1]
A Phase 1 clinical trial evaluating BXCL501 for efficacy and safety in agitation associated with pediatric schizophrenia and related disorde…
-
FDA approval · 2026-04-10FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lamotrigine Kit, a generic lamotrigine product by OWP Pharmaceuticals, Inc.
-
FDA approval · 2026-04-09FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Lamotrigine submitted by Aurobindo Pharma Limited.
-
FDA approval · 2026-04-09FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for a generic lamotrigine product from Unichem Pharmaceuticals (USA), Inc.
-
EMA approval · 2026-04-08EMA Authorised: Aripiprazole Zentiva (aripiprazole) — Zentiva, k.s.
The EMA has authorised Aripiprazole Zentiva (aripiprazole) for the treatment of schizophrenia and bipolar disorder. The marketing authorizat…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
NIMH-sponsored clinical trial evaluating mood and anxiety disorders, including bipolar disorder and major depressive disorder, is currently …
-
FDA approval · 2026-04-08FDA Approved: VALPROIC ACID — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Valproic Acid from Bionpharma Inc., for a generic product under ANDA 073484. This action confirm…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum
A completed clinical trial update from the University of Liverpool evaluating long-acting injectable antipsychotics for mental ill-health du…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the adverse events of oral ABBV-932 in adults with depressive episodes assoc…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2) [Phase 3]
This clinical trial update describes a Phase 3 study (BALSAM-2) evaluating the efficacy and safety of KarXT for manic episodes in Bipolar I …
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder [Phase 2]
Phase 2 clinical trial assessing measures of acute psychomotor agitation in people with schizophrenia and bipolar disorder has completed. Th…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE) [Phase 3]
Open-label Phase 3 trial evaluating azetukalner for bipolar depression in bipolar I or II disorder. Enrollment is ongoing by invitation.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Transcranial Photobiomodulation for Bipolar Depression [NA]
This clinical trial update indicates that a study on transcranial photobiomodulation for bipolar depression (sponsored by Vielight Inc.) is …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder [Phase 2]
RAP-219 is being studied in a Phase 2 trial to assess its efficacy and safety in adults with Bipolar I Disorder, and the study is currently …
-
FDA approval · 2026-04-01FDA Approved: LAMOTRIGINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Lamotrigine from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. [Phase 3]
Phase 3 study to assess change in disease activity and adverse events with cariprazine for depressive episodes in pediatric participants (10…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) [Phase 3]
A Phase 3 randomized trial is evaluating Azetukalner versus placebo for depressive episodes in bipolar disorder (bipolar I or II); the study…
-
FDA approval · 2026-03-31FDA Approved: VALPROIC ACID — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for valproic acid submitted by ANI Pharmaceuticals, Inc. The approval covers changes to the product …